Loading clinical trials...
Loading clinical trials...
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
Conditions
Locations
2
United States
MeBO Research
Miami, Florida, United States
The Metabolomics Innovation Centre
Edmonton, Alberta, Canada
Start Date
February 1, 2016
Primary Completion Date
August 30, 2017
Completion Date
May 1, 2018
Last Updated
October 23, 2020
NCT05723913
NCT04715945
NCT05540678
NCT04700436
NCT06399068
NCT06067451
Lead Sponsor
Mebo Research, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions